NATCO PHARMA LIMITED |
Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 887.10 INR | -9.02% |
|
-32.39% | -35.70% |
| 13.02. | NATCO Pharmas konsolidierter Gewinn sinkt im 3. Quartal des Geschäftsjahres; Aktien brechen um 19% ein | MT |
| 13.02. | NATCO Pharma Limited, Q3 2025 Earnings Call, Feb 13, 2025 |
NATCO Pharma Limited Gruppe: Beziehungs-Chart
Private Unternehmen, die zur gleichen Gruppe wie NATCO PHARMA LIMITED gehören
| Unternehmen | Geschäftsführender Direktor |
|---|---|
Natco Pharma (Canada), Inc.
 Natco Pharma (Canada), Inc. Pharmaceuticals: MajorHealth Technology Part of NATCO Pharma Ltd., Natco Pharma (Canada), Inc. is a Canadian subsidiary that specializes in the research, development, and manufacturing of drug products. The company is a vertically integrated manufacturer, controlling all stages of manufacturing from active pharmaceutical ingredients to finished dosage formulations. Natco is committed to increasing access to affordable medicines of the highest quality and supply reliability. Since 2006, Natco has been serving Canadian patients and is a trusted supplier of medicines, working with the world's largest drug companies. The company is based in Mississauga, Canada. The company was founded in 2012, and the CEO is Glenn Ikeda. | Glenn Ikeda |
MarketScreener is also available in this country: United States.
Switch edition